United States · FDA National Drug Code directory
TERBUTALINE SULFATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0115-2611_63142944-3083-4d47-908f-2984144b6c5d
- Product NDC
- 0115-2611
- Form
- TABLET
- Composition / generic term
- TERBUTALINE SULFATE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20010626
- Source listing expiry
- 20261231
Source-listed ingredients
- TERBUTALINE SULFATE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (0115-2611-01) · 0115-2611-01
- 500 TABLET in 1 BOTTLE (0115-2611-02) · 0115-2611-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →